Carnegie Investment Counsel’s Exponent EXPO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-2,735
Closed -$241K 504
2023
Q4
$241K Sell
2,735
-316
-10% -$25.9K 0.01% 443
2023
Q3
$261K Hold
3,051
0.01% 438
2023
Q2
$285K Buy
3,051
+53
+2% +$4.99K 0.01% 434
2023
Q1
$299K Hold
2,998
0.01% 434
2022
Q4
$297K Sell
2,998
-375
-11% -$36.4K 0.01% 428
2022
Q3
$296K Sell
3,373
-3,899
-54% -$370K 0.01% 404
2022
Q2
$665K Hold
7,272
0.03% 296
2022
Q1
$786K Sell
7,272
-41
-0.6% -$3.95K 0.03% 292
2021
Q4
$854K Buy
7,313
+4,187
+134% +$492K 0.03% 288
2021
Q3
$354K Buy
3,126
+125
+4% +$13.5K 0.01% 366
2021
Q2
$268K Buy
3,001
+1
+0% +$94 0.01% 416
2021
Q1
$292K Buy
+3,000
New +$281K 0.01% 381

Other funds holding EXPO

Carnegie Investment Counsel's EXPO Position: Q1 2024 in Review

Carnegie Investment Counsel sold out of Exponent (EXPO) in Q1 2024, closing a stake of 2,735 shares — an estimated $241K sold.

Carnegie Investment Counsel first reported a position in EXPO in Q1 2021 and held it in 12 quarters. The position peaked at $854K in Q4 2021. 329 funds tracked by Wall St. Rank hold EXPO as of Q1 2024.

  • Carnegie Investment Counsel reported no remaining Exponent position as of Q1 2024 after selling out during the quarter.
  • Carnegie Investment Counsel sold 2,735 Exponent shares in Q1 2024, an estimated $241K.
  • Carnegie Investment Counsel first reported a position in Exponent in Q1 2021 and held it in 12 quarters.
  • Carnegie Investment Counsel's Exponent position peaked at $854K in Q4 2021.
  • 329 funds tracked by Wall St. Rank held Exponent as of Q1 2024.

Based on Carnegie Investment Counsel's 13F filing for Q1 2024, filed 6 May 2024.